Inventor · disambiguated record
Kin S. Yang
Also filed as: YANG KIN S · YANG KIN SHING
15 granted patents·7 pending applications·34 citations·filing 2018–2025
89Inventor score
Top patents by PatentIndex Score
22 records- 0196US11584738B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 21, 2023·11 cites·47 claims
- 0294US11702407B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Jul 18, 2023·5 cites·26 claims
- 0394US11548871B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Jan 10, 2023·3 cites·30 claims
- 0493US11912686B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Feb 27, 2024·3 cites·5 claims
- 0593US10774071B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Sep 15, 2020·7 cites·18 claims
- 0691US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 0783US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 0878US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 0977US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 1077US12139474B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Nov 12, 2024·0 cites·4 claims
- 1172US11999717B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jun 4, 2024·0 cites·23 claims
- 1272US2025304554A1Lpa receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1368US11939318B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 1460US12269812B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 8, 2025·0 cites·11 claims
- 1559US12503454B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Dec 23, 2025·0 cites·36 claims
- 1656US11980609B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted May 14, 2024·0 cites·14 claims
- 1753US2025115600A1Covalent modifiers of akt1 and uses thereofTERREMOTO BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1851US2024409609A1Reversible lysine covalent modifiers of egfr and uses thereofTERREMOTO BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1948US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2047US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 2142US2025289789A1Reversible lysine covalent modifiers of cdk2 and uses thereofTERREMOTO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2241US2025289820A1Non-covalent modifiers of akt1 and uses thereofTERREMOTO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kin S. Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →